Clinical Trial Update: Broncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction Patients [NA]

View source ↗

Summary

This is a completed clinical trial evaluating broncho-adventitial delivery of paclitaxel to extend airway patency in patients with malignant airway obstruction …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Mercator MedSystems, Inc. | Conditions: Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer | NA | Status: COMPLETED